Antibody blood-brain barrier efflux is modulated by glycan modification.
about
Integration of genetic and metabolic features related to sialic acid metabolism distinguishes human breast cell subtypes.Antibody Engineering for Optimized Immunotherapy in Alzheimer's Disease.Elimination of substances from the brain parenchyma: efflux via perivascular pathways and via the blood-brain barrier
P2860
Antibody blood-brain barrier efflux is modulated by glycan modification.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Antibody blood-brain barrier efflux is modulated by glycan modification.
@en
Antibody blood-brain barrier efflux is modulated by glycan modification.
@nl
type
label
Antibody blood-brain barrier efflux is modulated by glycan modification.
@en
Antibody blood-brain barrier efflux is modulated by glycan modification.
@nl
prefLabel
Antibody blood-brain barrier efflux is modulated by glycan modification.
@en
Antibody blood-brain barrier efflux is modulated by glycan modification.
@nl
P2093
P2860
P1476
Antibody blood-brain barrier efflux is modulated by glycan modification.
@en
P2093
Emily E Wing
Hali A Hill
John M Finke
Kari R Ayres
Ryan P Brisbin
P2860
P304
P356
10.1016/J.BBAGEN.2017.06.008
P577
2017-06-14T00:00:00Z